Earnings GuidanceFQ2 guidance was underwhelming, as revenues are expected to be flat sequentially, while NG EPS at the midpoint of the guide is expected to down ~11% q/o/q.
Financial PerformanceRegional sales declined significantly year-over-year in the Americas and EMEA, with a sequential decline across all regions.
Sector PerformanceHealthcare declined 10%, Industrial was down 2%, and A&D fell 13%, QoQ.